financetom
Business
financetom
/
Business
/
IBM Q3 Adjusted EPS, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IBM Q3 Adjusted EPS, Revenue Increase
Oct 24, 2024 3:51 AM

04:24 PM EDT, 10/23/2024 (MT Newswires) -- IBM ( IBM ) reported Q3 non-GAAP earnings Wednesday of $2.30 per diluted share, up from $2.20 a year earlier.

Analysts polled by Capital IQ expected $2.23.

Revenue for the quarter ended Sept. 30 was $14.97 billion, up from $14.75 billion a year earlier.

Analysts surveyed by Capital IQ expected $15.08 billion.

Price: 221.00, Change: -11.75, Percent Change: -5.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Champion Homes CEO Mark Yost Steps Down, Chief Growth Officer Named Successor
Champion Homes CEO Mark Yost Steps Down, Chief Growth Officer Named Successor
Dec 13, 2024
04:48 PM EST, 12/13/2024 (MT Newswires) -- Champion Homes ( SKY ) late Friday said Mark Yost has stepped down as chief executive and president, and is succeeded by Tim Larson, currently chief growth officer at the modular home builder. Larson began at Champion Homes ( SKY ) in 2021 following stints as CEO at privately held Jostens, and chief...
Talen Energy Closes $850 Million Incremental Term Loan Financing, Related Share Repurchase
Talen Energy Closes $850 Million Incremental Term Loan Financing, Related Share Repurchase
Dec 13, 2024
04:52 PM EST, 12/13/2024 (MT Newswires) -- Talen Energy ( TLN ) said late Friday it has closed its upsized $850 million incremental Term Loan B financing and the repurchase of its common shares with a proportional value from affiliates of Rubric Capital Management. The company said it repurchased $1 billion of its shares using proceeds from the term loan...
Kyverna Therapeutics Picks Former Atara Bio, Kite Executives for Leadership Roles
Kyverna Therapeutics Picks Former Atara Bio, Kite Executives for Leadership Roles
Dec 13, 2024
04:50 PM EST, 12/13/2024 (MT Newswires) -- Kyverna Therapeutics ( KYTX ) said late Friday it appointed Dan Maziasz and Cara Bauer as chief business officer and chief human resources officer, respectively. Maziasz was previously the chief business officer at Atara Biotherapeutics ( ATRA ) , according to Kyverna. Bauer most recently served as global head of human resources at...
Intensity Therapeutics Says Stockholder Armistice Capital May Sell 1.24 Million Shares
Intensity Therapeutics Says Stockholder Armistice Capital May Sell 1.24 Million Shares
Dec 13, 2024
04:48 PM EST, 12/13/2024 (MT Newswires) -- Intensity Therapeutics ( INTS ) said stockholder Armistice Capital may offer and resell almost 1.24 million shares. The shareholder will get all of the proceeds from any sales, Intensity Therapeutics ( INTS ) said Friday in a regulatory filing. The timing and amount of any sale are at the sole discretion of Armistice....
Copyright 2023-2026 - www.financetom.com All Rights Reserved